Keywords
Abstract
Postmenopauzada endometriya salomatligi klinik jihatdan alohida ahamiyatga ega, chunki ushbu davrda endometriya atrofiya, giperplaziya va, ba’zan, karsinomaga o‘tish xavfi bilan bog‘liq bo‘ladi. Ushbu maqola postmenopauzal ayollarda endometriya holati, patofiziologiyasi va xavf omillarini tahlil qiladi. Shuningdek, atrofiya va giperplaziyadan malign transformatsiyaga o‘tish mexanizmlari, diagnostika usullari va klinik monitoringning ahamiyati ko‘rib chiqiladi.
References
1. Colombo, N., et al. (2016). ESMO–ESGO–ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Annals of Oncology, 27(1), 16–41.
2. Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014). WHO Classification of Tumours of Female Reproductive Organs. 4th edition. Lyon: IARC.
3. Trimble, C. L., et al. (2006). Endometrial Hyperplasia and Risk of Progression to Endometrial Cancer. Obstetrics & Gynecology, 108(3), 523–530.
4. Giannella, L., et al. (2016). Endometrial Atrophy, Hyperplasia and Carcinoma in Postmenopausal Women: Diagnostic and Therapeutic Approaches. Menopause, 23(6), 650–657.
5. Lethaby, A., et al. (2013). Endometrial Surveillance for Postmenopausal Bleeding: A Systematic Review. Cochrane Database of Systematic Reviews, 2013(1), CD001416.
6. Amant, F., et al. (2005). Endometrial Cancer in Postmenopausal Women: Risk Factors and Clinical Implications. The Lancet Oncology, 6(12), 1019–1027.
7. Stewart, C. J., et al. (2017). Pathophysiology and Management of Endometrial Atrophy and Hyperplasia in Postmenopausal Women. Maturitas, 103, 1–7.